Research Department, Pharmaceuticals Division, Ciba-Geigy Corp.,
Summit, New Jersey
 |
Introduction |
ZD6169, the
S-enantiomer of the racemic compound
N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide
recently discovered by Zeneca Pharmaceuticals Group (fig.
1), was reported to reduce the spontaneous mechanical
activity in isolated guinea pig bladder detrusor (Li et al.,
1995
) and to inhibit contraction of normal and unstable bladder in rat
and dog (Howe et al., 1995
). These actions are considered
potentially beneficial for the treatment of urinary urge incontinence,
which is closely associated with instability or hyperreflexia of
bladder detrusor smooth muscle. The results from electrophysiological
and several functional studies demonstrated that ZD6169 selectively
opened the KATP channels in smooth muscle cells, which led
to membrane hyperpolarization and inhibition of the contractile force
of the bladder muscle (Li et al., 1995
; Trivedi et
al., 1995b
).
Multiple types of K+ channel, including KATP,
KV and BKCa channels, are present in bladder
detrusor cells (Klockner and Isenberg, 1985
; Bonev and Nelson, 1993
;
Trivedi et al., 1995a
; Heppner and Nelson, 1995
). The
BKCa channel in spontaneously active bladder detrusor,
unlike in many other types of vascular and nonvascular smooth muscle
tissue, plays a predominant role in modulation of membrane excitability
and myogenic contractility. As evidence of this notion, several reports
showed that the application of BKCa channel blockers like
chTX, ibTX and tetraethylammonium (TEA) drastically augmented the basal
as well as stimulated contractile activity (Suarez-Kurtz et
al., 1991
; Zografos et al., 1992
; Shetty et
al., unpublished data). Relative to the BKCa channel,
KATP channel in bladder detrusor contributes little to the
muscle excitability, because glyburide, a specific KATP
channel blocker, modifies neither the spontaneous myogenic activity nor
86Rb efflux in the absence of KATP channel
openers (Zografos et al., 1992
; Shetty et al.,
unpublished data). In light of the unique regulatory role of
BKCa channel in bladder function in combination with the
reported in vivo bladder selectivity of ZD6169 compared with
cromakalim (Howe et al., 1995
), it is speculative that
ZD6169 may also interact with BKCa channel. To this end,
the present study attempted to establish a profile of the
electrophysiological actions of ZD6169 and its racemic compound
on individual components of KATP and BKCa
currents in freshly isolated guinea pig detrusor muscle cells. The
results revealed a complex mode of action of this compound on
KATP channel and a direct opening activity on the
BKCa channel. ZD6169 thus appears to be a dual
K+ channel opener.
 |
Methods |
Cell isolation.
Male guinea pigs (~300 g) were sacrificed
by exposure to CO2 for 2 min. The urinary bladder was
removed and rinsed in a Ca++-free medium composed of 135 mM
NaCl, 5.4 mM KCl, 2 mM MgSO4, 5 mM glucose, 10 mM HEPES and
pH 7.3 adjusted with NaOH. The detrusor muscle was cut and cleaned free
of connective tissue and blood vessels. Pieces of tissue were then
incubated for two periods of 35 min at 36°C in an enzyme medium
containing 130 mM K glutamate, 20 mM taurine, 5 mM pyruvate, 5 mM
creatine, 10 mM HEPES and 0.5 mM CaCl2 complemented with 1 mg/ml collagenase (Sigma, C2139), 0.2 mg/ml pronase (Sigma, P5147), 1 mg/ml fatty acid-free albumin. During incubation, tissue pieces were
gently stirred to assure a full exposure to the enzymes. After a total
of 70 min enzyme digestion, single bladder smooth muscle cells were
obtained by gentle agitation of the preparation through a Pasteur
pipette into the "KB" solution (Isenberg and Klockner, 1982
).
Single cells were stored at 4°C for 1 h before recording.
Experimental setting and current recording.
Experiments were
performed at 22°C with the whole-cell or inside-out configurations of
the patch-clamp technique (Hamill et al., 1981
) in
enzymatically dispersed smooth muscle cells from guinea pig bladder
detrusor. Patch electrodes were pulled from Kimax-51 capillary tubes
(Kimble Products, Vineland, NJ). The resistance of electrodes after
fire polishing was around 2 megohm for the whole-cell mode to increase
the rate of solution dialysis and around 5 megohm for the inside-out
mode to reduce the number of channels recorded. Whole-cell currents
were amplified by a List EPC-7 amplifier (Adams & List Assoc.,
Darmstadt, Germany), digitized at 4 kHz with a TL-1-125 DMA interface
(Axon Instruments) and stored on a Compaq DeskPro/66 M microcomputer
for later analysis with pClamp version 6.03 (Axon Instruments, Foster
City, CA). The inside-out single-channel recordings were first
low-pass-filtered at 2 kHz by an 8-poles Bessel filter (Frequency
Devices 902LPF) and video-taped with a Toshiba Pulse-Code Modulation
data recorder (DX-900). After each experiment, the recordings were
played back through a window discriminator (AI2020, Axon Instruments)
at a sampling rate of 4 kHz and stored on the computer for analysis. The junction potential between the electrodes and the bath solution was
compensated by the DC offset on the amplifier. No leak subtraction was
applied. The cell capacitance was 34.8 ± 2.5 pF
(n = 16).
Two distinct voltage-clamp protocols, a ramp and a step, were used for
the whole-cell recordings. The ramp experiments were designed to study
the effect of ZD6169 on the KATP current. Cells were
clamped at
50 mV and a voltage ramp ranging between
110 mV and +30
mV or between
110 mV and +110 mV with a duration of 1.5 s was
applied. The bath solution was composed of 140 mM KCl, 5 mM NaCl, 1 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES and 5 mM
glucose; and the pipette solution had 140 mM KCl, 1 mM
MgCl2, 0.1 mM CaCl2, 0.6 mM EGTA, 2 mM
Na2UDP, 0.5 mM K2ATP, 5 mM glucose and 10 mM HEPES, in which the free Ca++ concentration was estimated
to be 10
8 M (Imai and Takeda, 1967
). The step
voltage-clamp experiments were used to study the effect of ZD6169 on
the BKCa current. Cells were subjected to depolarization
steps from
30 to +75 mV in a 15-mV increment from a holding potential
of 0 mV. The bath solution contained 140 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES and 5 mM
glucose; and the pipette solution was basically same as in the ramp
experiments except that the concentration of K2ATP was
increased to 2 mM, with which the time-independent KATP
current was presumably inactivated. In inside-out single-channel recordings, the pipette and the bath solutions had the same composition of 140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 10 mM HEPES and 5 mM
glucose; except for the CaCl2 concentration, which was
10
3 M in the pipette and 10
8 M in the bath
buffered with EGTA.
ZD6169 and its racemic compound were synthesized in the Research
Department of Ciba-Geigy Corp. The drugs were first dissolved in 95%
ethyl alcohol to form a stock solution of 50 mM, which was then diluted
with saline to the desired concentrations shortly before experiments.
In this study, vehicle control experiments were performed and showed
that ethyl alcohol at a maximal concentration of 0.1% had no
discernible electrophysiological effects on K+ channels.
 |
Results |
Concentration-dependent dual effect of ZD6169 on
KATP current.
The effect of ZD6169 on the
KATP current was investigated when cells were bathed in
symmetrical K+ (140 mM) solutions to increase inward
current and clamped at
50 mV to minimize activation of other
voltage-dependent K+ currents at negative membrane
potentials. Current was elicited by a ramp protocol ranging from
110
mV to +110 mV over a period of 1.5 s. With only 0.5 mM ATP in the
pipette solution, the steady-state holding current was presumably
composed of leakage current and a basal activity of KATP
channels. In the absence of ZD6169, small inward current, basically
KATP channel in isolation, was detected at potentials
negative to 0 mV (fig. 2A). To better display the modification of inward KATP current by the drug, a
high-current magnification was used in figure 2, in which the sizable
outward rectifying current at the positive voltages was largely out of scale. The inward KATP current was increased by ZD6169 at
0.5 µM (fig. 2B) and 5 µM (fig. 2C) in a concentration-dependent
manner. As the concentration of ZD6169 further increased to 50 µM,
the stimulatory effect on the KATP current diminished and a
significant inhibitory effect manifested instead (fig. 2D). This dual
effect on the KATP channel was observed in 10 of 12 cells
studied. Additional studies in which the concentration increment was
made smaller showed that a maximal activation of KATP
channel by ZD6169 occurred between 5 and 10 µM, depending on
individual cell. The effects on KATP channel were fully
reversible upon washout of ZD6169 (fig. 2E). The current activated by
ZD6169 (5 µM) was completely prevented (fig. 3, A-C)
and reversed (fig. 3, A, C and D) by 1 µM glyburide, a specific
KATP channel blocker, which indicated that ZD6169-activated current was, by nature, the KATP current.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 2.
Concentration-dependent dual action of ZD6169 on
KATP channel. These recordings are representative of the
whole-cell currents in response to a 1.5-s voltage ramp from 110 to
+110 mV (as shown at the top) in control (A), in the presence of ZD6169
at 0.5 µM (B), 5 µM (C) and 50 µM (D), and after washout of the
drug (E). The cell was bathed in symmetrical 140 mM K+
solutions and held at 50 mV. Calcium concentration was
10 3 and 10 8 M in bath and pipette solution,
respectively. The pipette solution contained 0.5 mM ATP to facilitate
the activation of KATP channels. A high magnification is
used to better display the changes in the inward KATP
current, whereas a large portion of current at positive potential,
rectifying outwardly, is out of scale. Dashed lines indicate the zero
current level. The scale of a 0.5 nA reference current is shown at the
lower left corner.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
ZD6169-activated current is sensitive to glyburide.
Whole-cell currents were elicited in response to a 1.5-s voltage ramp from 110 mV to +30 mV (as shown at the top) in control (A), in 5 µM
ZD6169 with 1 µM glyburide (B), in 5 µM ZD6169 alone (C) and again
in 5 µM ZD6169 and 1 µM glyburide (D). The cell was bathed in
symmetrical 140 mM K+ solution and held at 50 mV. The
pipette solution contained 0.5 mM ATP. Dashed lines indicate the zero
current level. The scale of a 0.5 nA reference current is shown at the
lower left corner.
|
|
Activation of BKCa current by ZD6169.
The effect of ZD6169 on the BKCa current was investigated
when cells were bathed in physiological solutions
([K+]i 140 mM/[K+]o
5 mM) and clamped at 0 mV to inactivate other voltage-dependent K+ currents, allowing the demonstration of BKCa
channel alone in response to a series of voltage steps (Olesen et
al., 1994
). The pipette solution contained 2 mM ATP, a
concentration considerably higher than 40 to 50 µM, the concentration
generally found to half-maximally inhibit the KATP channel.
Voltage steps ranging between
30 mV and +75 mV with an increment of
15 mV from a holding potential of 0 mV elicited a family of noisy,
time-dependent and noninactivating currents (fig. 4, A
and D), of which more than 85% were blockable by 2 mM TEA (fig. 4, B
and C) and 80 nM ibTX (fig. 4, E and F), which indicated a predominant
contribution of the BKCa channel to the current. Figure
5 shows the effects of ZD6169 at concentrations of 0.5, 5 and 50 µM on the whole-cell BKCa currents in a typical
experiment. In 13 of 14 cells tested, significant activation of the
BKCa currents by ZD6169 was observed only at concentrations
equal to or higher than 20 µM (fig. 5D). However, in 4 of 13 responsive cells ZD6169 caused a dose-dependent augmentation of the
BKCa currents at concentrations ranging between 0.5 and 50 µM. The BKCa channel-activating effect had a rapid onset
and offset, and was fully reversible within 1 to 2 min (fig. 5E).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Whole-cell BKCa currents are sensitive
to TEA and ibTX. A family of whole-cell BKCa currents were
elicited by a voltage-step protocol ranging from 30 mV to +75 mV with
an increment of 15 mV from a holding potential of 0 mV in control (A),
in 2 mM TEA (B) and the current-voltage relationship of A (circles) and
B (squares). Data in A, B and C were obtained from the same cell. Results of a parallel experiment from another cell in control (D), in
80 nM ibTX (E) and the current-voltage curves for D (triangles) and E
(diamonds). The voltage-step protocol had a duration of 1 s. The
cell was bathed in physiological K+ solutions
([K+]i 140 mM/[K+]o
5 mM). The pipette solution contained 2 mM ATP.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
ZD6169 activates BKCa current.
Whole-cell currents were elicited by a voltage-step protocol ranging
from 30 mV to +75 mV with an increment of 15 mV and a duration of
1 s (as shown at the top) in control (A), during subsequent
exposure to ZD6169 at 0.5 (B), 5 (C) and 50 µM (D), and after washout
of the drug (E). A holding potential of 0 mV was used to inactivate
other voltage-dependent K+ currents. The cell was bathed in
physiological K+ solutions ([K+]i
140 mM/[K+]o 5 mM). The pipette solution
contained 2 mM ATP. The scale of a 5 nA reference current is shown at
the lower left corner.
|
|
Voltage dependence of the effects of ZD6169.
The instantaneous
current-voltage relationship in the absence and presence of ZD6169 was
assessed in a conventional way by use of the ramp protocol used in
figure 2; the results are shown in figure 6. The
KATP current (most visible in the inward direction) underwent a reversible stimulation and a suppression as the
concentration increased (fig. 6, A-E). The current at potentials
positive to 0 mV, rectifying in an outward direction, was largely
composed of the current through the BKCa channels. A
reversible augmentation of this current component by ZD6169 at 50 µM
is readily visible in figure 6D. Figure 6F illustrates the overall
effects of ZD6169 on KATP and BKCa currents.
The increase (from the control) in the amplitude of the maximum inward
KATP current measured at
110 mV in the ramp experiments
was 15.0 ± 6.3%, 52.1 ± 12.7% and
29.6 ± 4.1%
(n = 12); whereas the increase (from the control) of
the BKCa current at +60 mV in the step experiments was
10.0 ± 2.3%, 15.2 ± 3.2% and 47.5 ± 3.3%
(n = 14), respectively, in the presence of 0.5, 5 and
50 µM of ZD6169.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of ZD6169 on current-voltage relationship.
Whole-cell currents were recorded with a voltage ramp ranging from
110 mV to +110 mV over a period of 1.5 s (as shown at the top)
in control (A), in ZD6169 at 0.5 µM (B), 5 µM (C) and 50 µM (D), and after washout of the drug (E). The holding potential was 50 mV.
The cell was bathed in symmetrical 140 mM K+ solutions. The
pipette solution contained 0.5 mM ATP. Dashed lines indicate the zero
current level. The scale of a 2 nA reference current is shown at the
lower left corner. Panel F illustrates the changes (from the control)
in the maximum inward KATP current measured at 110 mV in
the ramp voltage-clamp experiments (hatched bars) and in the
BKCa current measured at +60 mV in step voltage-clamp experiments (filled bars) induced by ZD6169 at 0.5, 5 and 50 µM. The
abscissa gives the concentration of ZD6169 (µM), and the ordinate denotes changes of the current, which were calculated according to the
formula: % change = (IK in ZD6169 IK in control)/(IK in control).
|
|
Activation of BKCa by ZD6169 (50 µM) is
independent of Ca++.
The results in figure 6F
demonstrated that ZD6169 at 50 µM caused simultaneously an inhibition
of the KATP current and an activation of the
BKCa current. The former effect would presumably lead to
membrane depolarization followed by the opening of the voltage-dependent Ca++ channels. It was therefore
speculated that the stimulation of the BKCa channel might
be secondary to the inhibition of KATP channels
via an increase in intracellular free Ca++. We
investigated whether Ca++ signaling bridged these two
events by scrutinizing the Ca++ dependence of
ZD6169-induced BKCa channel activation. It was found that
ZD6169 stimulated the whole-cell BKCa current by a similar
magnitude in the presence and absence of Ca++ in the bath
(data not shown), which indicated that the effect is independent of
extracellular Ca++ concentration. The effect was also
unaffected by the addition of up to 12 µM nifedipine, a
Ca++ channel blocker, to the bath. Figure 7
shows the effect of 50 µM ZD6169 on the whole-cell BKCa
currents elicited by depolarization steps in the absence (fig. 7, A-C)
and in the presence (fig. 7, D-F) of 1 µM nifedipine. Apparently,
the activation of the BKCa currents by ZD6169 persisted
regardless of blockade of the voltage-dependent Ca++
influx. Thus, the effect was independent of the change in
[Ca++]i resulting from Ca++
influx.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of ZD6169 on BKCa currents is
independent of Ca++ influx. Whole-cell BKCa
currents were augmented by 50 µM ZD6169 in the absence (A, B and C)
and presence of 1 µM nifedipine (D, E and F). Currents were elicited
by a voltage-step protocol ranging from 30 mV to +75 mV with an
increment of 15 mV from a holding potential of 0 mV (as shown at the
top). The bath and pipette solutions contained, respectively,
10 3 and 10 8 M Ca++. The
BKCa currents in control (A) were activated during exposure to 50 µM ZD6169 (B), and reversed upon washout of ZD6169 (C). Current
recordings of a parallel experiment but in the presence of 1 µM
nifedipine throughout were made in another cell (D, E and F). The
ordinates in A and D indicate the current scales. The scales in B and C
are the same as in A, and those in E and F are the same as in D.
|
|
To further assess the possibility that BKCa channel
activation may be triggered by an increase in
[Ca++]i subsequent to Ca++
release from intracellular store, we examined the effect of ZD6169 on
single BKCa channels in inside-out cell-detached patches,
in which the intracellular organelles were absent and
[Ca++]i was clamped by EGTA at a constant
level of 10
8 or 10
9 M. The BKCa
channel in guinea pig detrusor muscle cells had a conductance of
208.5 ± 5.9 pS (n = 23) in symmetrical 140 mM
K+ solutions. Its activity was highly dependent on
[Ca++]i and membrane potential. The
relationship between the channel open-state probability
(NPo) and voltage (V) followed a Boltzmann distribution (Hu
et al., 1989
), which shifted toward more negative voltage by
11 mV when [Ca++]i was increased from
10
9 to 10
8 M. With such a change in
[Ca++]i, the voltage sensitivity of the
channel remained unchanged. An e-fold increase in NPo took
place with a 10.2-mV membrane depolarization, a value well within the
range of the voltage sensitivities of the Ca++-activated
K+ channels in a variety of cell types (Marty, 1983
; Singer
and Walsh, 1987
). As [Ca++]i was raised to
10
7 M, the channel became so active that it virtually
maintained a steady open state at all voltages tested. Figure
8 shows typical single-channel recordings in the absence
and presence of ZD6169 at concentrations of 0.5, 5 and 50 µM as
[Ca++]i was made at 10
8 M. When
ZD6169 was applied in the bath of inside-out patches (intracellular
side), it did not affect the single-channel conductance but increased
NPo of BKCa channel by 41.5 ± 20.5%,
56.2 ± 5.5% and 297.7 ± 117.2% (n = 6),
respectively. Parallel experiments were performed when
[Ca++]i was clamped at 10
9 M,
in which ZD6169 at 0.5, 5 and 50 µM caused, respectively, an increase
in NPo by 11.8 ± 6.2%, 151.3 ± 23.7% and
238.9 ± 95.5% (n = 4). Because of the overly
high basal activity of the channel at [Ca++]i
of 10
7 M, a quantitative assessment of changes in channel
activity induced by ZD6169 was not possible. In summary, the
single-channel experiments demonstrated 1) ZD6169 activated the
BKCa channel as [Ca++]i was kept
constant; 2) the magnitude of activation did not apparently correlate
with [Ca++]i.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 8.
ZD6169 activates single BKCa channels
in an inside-out patch. Representative single BKCa
recordings (from top to bottom) in control, in the presence of ZD6169
at 0.5, 5 and 50 µM, and after washout of the drug. Recordings were
made from an inside-out patch held at +50 mV and exposed to symmetrical
K+ (140 mM) solutions with a free Ca++
concentration of 10 8 M in bath solution. In all panels,
two current traces are consecutive recordings with a total duration of
20 s. Upward deflections are the opening events of the channel,
whose closed state is indicated by the short lines at the left of the
traces. Currents were filtered at 2 kHz.
|
|
Effects of racemic ZD6169 on KATP and
BKCa channels.
ZD6169 was reported to
display a stereoselectivity. Being the active S-enantiomer,
ZD6169 is about 30-fold more potent than the R-enantiomer in
mechanoinhibitory activity (Li et al., 1995
). The racemic
ZD6169 was tested in experiments parallel with those with ZD6169.
Analogous to the experiment with ZD6169 (S-enantiomer) in
figure 2, figure 9 shows a typical
concentration-dependent dual effect of the racemic ZD6169 on inward
KATP current evoked by a voltage ramp. Likewise, the
opening effect on the BKCa current elicited by a step
voltage protocol is demonstrated in figure 10. It is
obvious that the effects of the racemic ZD6169 on the KATP
and the BKCa currents were not dissimilar to those of
ZD6169. All effects were readily reversible.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 9.
Concentration-related dual action of racemic ZD6169
on KATP current. These recordings are representative of the
whole-cell current in response to a 1.5-sec voltage ramp from 110 to
+30 mV (as shown at the top) in control (A), in the presence of ZD6169 at 0.5 µM (B), 5 µM (C) and 50 µM (D). The cell was bathed in symmetrical 140 mM K+ solutions and held at 50 mV.
Calcium concentration was 10 3 and 10 8 M in
bath and pipette solution, respectively. The pipette solution contained
0.5 mM ATP. Dashed lines indicate the zero current level. A 0.5 nA
reference current is shown at bottom left of the figure.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 10.
Racemic ZD6169 activates BKCa current.
Whole-cell currents were elicited by a voltage-step protocol ranging
from 30 mV to +75 mV with an increment of 15 mV and a duration of
1 s (as shown at the top) in control (A), during subsequent
exposure to ZD6169 at 0.5 (B), 5 (C), and 50 µM (D), and after
washout of the drug (E). The holding potential was 0 mV. The cell was
bathed in physiological K+ solutions
([K+]i 140 mM/[K+]o
5 mM). The pipette solution contained 2 mM ATP. A 2 nA reference current is shown at lower left corner.
|
|
 |
Discussion |
Zeneca ZD6169, an anilide tertiary carbinol, represents a new
structural class of K+ channel openers and is currently
under the development by Zeneca Pharmaceuticals Group as an
intervention therapy for urinary urge incontinence. As a bladder smooth
muscle relaxant agent, its mechanism of action has recently been
investigated. Results from several functional and electrophysiological
assays provided evidence showing that ZD6169 exerts its
mechanoinhibitory action in bladder detrusor by opening the
KATP channels (Li et al., 1995
; Trivedi et
al., 1995b
). The present study has shown that the pharmacology of
ZD6169 is more complex than originally described, and the drug
possesses multiple excitatory and inhibitory effects on multiple types
of K+ channel.
In this study, the KATP current was measured with voltage
ramp protocols at voltages negative to 0 mV after optimizing the conditions for the detection of the current. Cells were bathed in
symmetrical K+ (140 mM) solutions to increase inward
current and clamped at
50 mV to minimize activation of other
voltage-dependent K+ currents (Clapp et al.,
1994
). The intracellular ATP concentration was reduced to 0.5 mM to
facilitate the activation of the KATP channel. At voltages
negative to 0 mV where BKCa channel and delayed rectifier
K+ current were minimal, the inward KATP
current was visibly detected (figs. 2 and 3). After the application of
ZD6169 at lower concentrations (0.5-10 µM, fig. 2), significant
inward current was activated in a concentration-dependent manner. The
activated current had little voltage dependence and was completely
abolished by 1 µM glyburide (fig. 3), which indicated that ZD6169
acted to open the KATP channel. Our observation is
consistent with the electrophysiological data reported by Li et
al. (1995)
. They showed that 10 µM ZD6169 induced a sustained
increase in whole-cell KATP current. A novel and unexpected
finding was the significant inhibition of KATP current by
ZD6169 at concentrations higher than 20 µM. The mechanism(s) underlying the transition from a stimulatory to an inhibitory action is
not clear at the present time and will be the subject of future study.
Collectively, the concentration-response curve of the effects of ZD6169
on the KATP current had a bell shape with a maximum
activation reached at a concentration of approximately 10 µM.
The chTX- and ibTX-sensitive BKCa channel has been reported
to play a predominant role in controlling cell excitability and contractility in guinea pig bladder muscle (Suarez-Kurtz et
al., 1991
; Zografos et al., 1992
; Shetty et
al., unpublished data). Although the presence of the
BKCa channel in guinea pig bladder smooth muscle cells was
explored earlier (Klockner and Isenberg, 1985
; Trivedi et
al., 1995a
), direct recording of the isolated BKCa
current is however lacking. In the present study, the whole-cell BKCa current was demonstrated in isolation by use of
voltage-step protocol with a holding potential of 0 mV, at which the
other voltage-dependent K+ current was inactivated and by
use of 2 mM ATP in the pipette solution to inhibit the KATP
current (Olesen et al., 1994
; Edwards et al.,
1994
). The single BKCa channel in guinea pig bladder cells was found to be highly dependent on membrane potential and
intracellular Ca++ with a voltage and Ca++
sensitivity similar to those of the conventional BKCa
channels in various types of cells (Marty, 1983
; Singer and Walsh,
1987
). The single-channel conductance of 209 pS in symmetrical
K+ (140 mM) solutions was also in a good agreement with the
conductances of typical BKCa channels in other tissues
(Lattore et al., 1989
). To our best knowledge, the
BKCa currents at whole-cell as well as single-channel level
in guinea pig bladder muscle cells, for the first time, were measured
directly, and the effects of ZD6169 on the channels were assessed.
An important observation of the present study was that over a similar
concentration range (>20 µM), ZD6169 not only inhibited the
KATP current, but also significantly enhanced the
BKCa current. This type of multiple inhibitory and
stimulatory actions is not unique to ZD6169 but is also shared by
reported BKCa channel openers NS004 (Xu et al.,
1994
; Hu et al., 1994
) and NS1619 (Edwards et al., 1994
). In theory, a closing of the KATP channel
and an opening of the BKCa channel over a similar
concentration range could be causally related, because the inhibition
of KATP channel would lead to membrane depolarization,
activation of Ca++ influx and hence stimulation of the
BKCa channel. However, this sequence of events did not
apply to the effects of ZD6169. We found that the augmentation of the
whole-cell BKCa current by ZD6169 was unaffected by the
removal of extracellular Ca++ or by the presence of
Ca++ channel blocker, which suggested that the effect did
not involve changes in [Ca++]o or
[Ca++]i subsequent to Ca++
influx. In inside-out detached patches, ZD6169 was capable of opening
the channel when the cytosolic Ca++ concentration was held
constant. In addition, the magnitude of stimulation did not
significantly differ whether [Ca++]i was
10
9 or 10
8 M. Thus, the effect was
independent of the change in [Ca++]i. In
settings like detached patches, in which the activities of
intracellular biochemical or biophysical pathways are usually disrupted
because of a lack of substrates or cellular organelles, a second
messenger (e.g., IP3) mediated process for the
effect of ZD6169 on the BKCa channel was most unlikely,
although there was a report on the preservation of functional
intracellular Ca++ store sites in detached patches of
smooth muscle cells from rabbit portal vein (Xiong et al.,
1992
). It is therefore conceivable that the stimulatory effect of
ZD6169 on the BKCa channel is a direct interaction between
the drug and the channel gating, and the inhibition of KATP
channel is not causally linked to the activation of BKCa
channel through Ca++ signaling.
Based on the reported in vitro data that the
mechanoinhibitory effect of ZD6169 was antagonized by glyburide (Li
et al., 1995
), an opening of the KATP channel is
likely to be the primary mechanism of relaxant action. Our data in
figure 6 showed that ZD6169 is capable of augmenting the
BKCa channel with a magnitude comparable to the magnitude
of the activation of the KATP channel. Considering the
unique role of the BKCa channel in bladder muscle
excitability, the ZD6169-induced the BKCa channel
activation would also be an obligate mechanism underlying its bladder
relaxant effect. Although glyburide was reported to cause a rightward
shift of the concentration-response curve of ZD6169-induced relaxation
of guinea pig detrusor strips (fig. 4; Li et al., 1995
), the
shift was not strictly parallel when the concentration of ZD6169 was 10 µM or greater. A possible explanation could be that the relaxation
induced by ZD6169 at higher concentrations is not primarily caused by
an opening of the KATP channel but of the BKCa
channel.
The in vivo pharmacology of ZD6169 has recently been
assessed in comparison with cromakalim, a reference KATP
channel opener (Howe et al., 1995
). The results showed that
ZD6169 produced a bladder inhibitory profile similar to that of
cromakalim, but a significantly weaker cardiovascular activity than
cromakalim. It remains to be established whether this in
vivo selectivity derives from pharmacokinetic factors or ZD6169 is
able to exploit any possible difference between KATP
channels in different tissues. Nevertheless, the diverse activities of
ZD6169 on multiple types of K+ channels might, in part, be
responsible for the in vivo selectivity. The diminished
stimulatory effects on KATP channel as the drug concentration increases may contribute to the weaker effects on heart
rate and blood pressure, whereas a simultaneous activation of
BKCa channel may ameliorate the inhibitory effect on
bladder because of the pivotal role of the BKCa channel
(generally absent in cardiac tissues) in bladder contractility
(Suarez-Kurtz et al., 1991
; Zografos et al.,
1992
).
In summary, Zeneca ZD6169 exerts diverse actions on multiple types of
K+ channels in smooth muscle cells from guinea pig bladder
detrusor. Depending on the concentration, it produces a dual
stimulatory and inhibitory effect on KATP channel and a
stimulatory effect on the BKCa channel. An agent with such
an electrophysiological profile may be potentially beneficial for the
treatment of urinary urge incontinence with less undesired
cardiovascular side effects.
The authors thank Dr. Cynthia A. Fink for her effort in the
synthesis of racemic and S-enantiomer of ZD6169, which made
this study possible.
Accepted for publication September 6, 1996.
Received for publication April 22, 1996.